Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Serratus Posterior Superior Intercostal Plane Block on Perioperative Inflammatory Response and TLR4-Mediated Innate Immune Activation in Breast Cancer Surgery: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial

NCT07843212 is registered in ClinicalTrials.gov with Mucahide Emine Fidancı Kuas as lead sponsor.

NCT NCT07843212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07843212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Serratus Posterior Superior Intercostal Plane Block on Perioperative Inflammatory Response and TLR4-Mediated Innate Immune Activation in Breast Cancer Surgery: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial
Lead sponsor
Mucahide Emine Fidancı Kuas
Phase
Not applicable
Overall status
Recruiting
Start date
July 14, 2026
Completion date
January 30, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, serratus posterior superior intercostal plane block (spsipb), toll-like receptors